You have accessJournal of UrologyBenign Prostatic Hyperplasia: Surgical Therapy and New Technology II1 Apr 20122025 LONG TERM OUTCOME OF 43 PATIENTS WITH PARKINSON'S DISEASE AND BENIGN PROSTATIC OBSTRUCTION UNDERGOING A TRANSURETHRAL RESECTION OF THE PROSTATE Andreas Neisius, Yvonne Neisius, Jens Woellner, Joachim W. Thueroff, and Christian Hampel Andreas NeisiusAndreas Neisius Mainz, Germany More articles by this author , Yvonne NeisiusYvonne Neisius Worms, Germany More articles by this author , Jens WoellnerJens Woellner Zurich, Switzerland More articles by this author , Joachim W. ThueroffJoachim W. Thueroff Mainz, Germany More articles by this author , and Christian HampelChristian Hampel Mainz, Germany More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2012.02.2188AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookTwitterLinked InEmail INTRODUCTION AND OBJECTIVES According to the current literature patients with Parkinson's disease and Benign Prostatic Obstruction or Hypocontractility of the detrusor have an increased risk of a postoperative urinary incontinence after transurethral resection of the Prostate (TUR- P). The biggest population which has been published so far did not exceed 23 cases. We analysed the outcome after TUR- P in patients with a neurological proven Parkinson's disease. METHODS From 10/1987 until 08/2011 a total amount of 43 patients with proven Parkinson's disease underwent a TUR-P because of benign prostatic obstruction or detrusor hypocontractility and were retrospectively analysed. Patients with multiple system atrophy or any other systemic neurological disorders were excluded. RESULTS The median patient age at intervention was 75 years. Benign Prostate Syndrom (BPS)- patients without indwelling catheter or urgency incontinence (n=19) benefit most from TUR- P. The de novo- Stress incontinence rate was 2/19 (11%). 14 of 43 patients had a preoperative indwelling catheter, of whom 6 (43%) required an indwelling Foley catheter also after TUR- P. In 8 of these 14 patients (57%) voiding without PVR was possible postoperatively. In 2 patients (14%) a de novo stress urinary incontinence occurred. From another 10 patients with preoperative urgency incontinence 7 regained continence (70%), 2 were significantly less incontinent (20%) and only 1 (10%) remained as incontinent as before TUR-P. In 4 of 43 cases (9.3 %) a de novo urinary incontinence was ascertained three months after TUR-P. At a median follow up of 11 years transurethral resection in patients with a Parkinson's disease were successful in 30 of 43 (70%) cases. CONCLUSIONS Based on our results patients with Parkinson's disease and benign prostatic obstruction or detrusor hypocontractility do benefit in up to 70% from a TUR-P. These patients have an increased risk of postoperative urinary incontinence (9.3%). According to the current literature the rate for postoperative de novo incontinence after TUR- P in patients without neurogenic risk factors ranges from 2.1 to 3.3 %. A preoperatively performed urodynamic test should be recommended to discriminate between bladder outlet obstruction and detrusor hypocontractility. In conclusion Parkinson's disease should not be esteemed as a mandatory contraindication for a TUR-P. © 2012 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 187Issue 4SApril 2012Page: e817 Advertisement Copyright & Permissions© 2012 by American Urological Association Education and Research, Inc.MetricsAuthor Information Andreas Neisius Mainz, Germany More articles by this author Yvonne Neisius Worms, Germany More articles by this author Jens Woellner Zurich, Switzerland More articles by this author Joachim W. Thueroff Mainz, Germany More articles by this author Christian Hampel Mainz, Germany More articles by this author Expand All Advertisement Advertisement PDF downloadLoading ...